Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wolinsky

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
Neurology|April 6, 2011
Interferon β-1b and glatiramer acetate effects on permanent black hole evolutionM Filippi, M A Rocca, F Camesasca, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS studyDavid H Miller, Fred D Lublin, Maria Pia Sormani, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosisKaarina Kowalec, Arvid Harder, Casandra Dolovich, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
International Journal of MS Care|November 12, 2020
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation StrategiesLori Saslow, David K B Li, June Halper, et al.
Science (New York, N.Y.)|November 13, 1999
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cellsZ Zhang, T Schuler, M Zupancic, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Annals of Neurology|August 7, 2025
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple SclerosisAli Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, et al.
Science (New York, N.Y.)|June 6, 1998
Genetic evaluation of suspected cases of transient HIV-1 infection of infantsL M Frenkel, J I Mullins, G H Learn, et al.
Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
Neurology|April 6, 2011
Interferon β-1b and glatiramer acetate effects on permanent black hole evolutionM Filippi, M A Rocca, F Camesasca, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS studyDavid H Miller, Fred D Lublin, Maria Pia Sormani, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosisKaarina Kowalec, Arvid Harder, Casandra Dolovich, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
International Journal of MS Care|November 12, 2020
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation StrategiesLori Saslow, David K B Li, June Halper, et al.
Science (New York, N.Y.)|November 13, 1999
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cellsZ Zhang, T Schuler, M Zupancic, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Annals of Neurology|August 7, 2025
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple SclerosisAli Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, et al.
Science (New York, N.Y.)|June 6, 1998
Genetic evaluation of suspected cases of transient HIV-1 infection of infantsL M Frenkel, J I Mullins, G H Learn, et al.
Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.
Pageof 34